How Cognitive Bias Undermines Value Creation in Life Sciences M&A


Published in In Vivo, September 2017

Author:  Oded Ben-Joseph, Ph.D.

Life Sciences mergers and acquisitions are typically based on perceived future value rather than objective financial parameters, but the cognitive biases inherent in subjective assessments can derail deals.  Executives need to take emotion out of the equation and rely on relevant data to craft successful transactions.

Mergers and acquisition transactions play a central role in the life sciences sector and are the catalyst for growth and transformation, driving innovation from the laboratory all the way to the patient.  Life sciences companies often fall victim to recurring misconceptions that lead to unnecessary failure.

View Full Article

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • New York

    555 Fifth Ave.
    19th Floor
    New York, NY 10017
    (212) 350-8213

  • Boston

    99 High St.
    Suite 2900
    Boston, MA 02110
    (617) 431-4886

  • Washington DC

    11921 Freedom Dr.
    Suite 730
    Reston, VA 20190
    (703) 225-1500